Cargando…
Invited commentary: When and how to initiate systemic therapy in treating favorable risk metastatic renal cell carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772631/ https://www.ncbi.nlm.nih.gov/pubmed/35069079 http://dx.doi.org/10.1097/CU9.0000000000000052 |